Работы, на которые ссылается эта работа

Работ: 40

Работа: Design, synthesis, in vitro evaluation of a new pyrrolo[1,2‐a]thiazolo[5,4‐d]pyrimidinone derivatives as cholinesterase inhibitors against Alzheimer's disease

Tricyclic Quinazoline Alkaloids: Isolation, Synthesis, Chemical Modification, and Biological Activity
Kh. М. Shakhidoyatov, Burkhon Elmuradov
СтатьяQuinazolinone synthesis and applicationsChemistry of Natural Compounds2014Цитирований: 16
ABI
6,7,8,9-Tetrahydropyridoquinazolines, a new class of alkaloids from Mackinlaya species (Araliaceae)
JS Fitzgerald, SR Johns, JA Lamberton +1
Статья1966Цитирований: 16
ABI
Design, synthesis, and toward a side-ring optimization of tricyclic thieno[2,3-d]pyrimidin-4(3H)-ones and their effect on melanin synthesis in murine B16 cells
Li Fei Nie, Khurshed Bozorov, Guozheng Huang +3
СтатьяQuinazolinone synthesis and applicationsPhosphorus, sulfur, and silicon and the related elements2018Цитирований: 14
ABI
<scp>2‐substituted</scp> tricyclic oxazolo[5,4‐d]pyrimidine library: Design, synthesis, and cytotoxicity activity
Yan Zeng, Lifei Nie, Khurshed Bozorov +4
СтатьяQuinazolinone synthesis and applicationsJournal of Heterocyclic Chemistry2021Цитирований: 11
ABI
Synthesis and in vitro biological evaluation of novel diaminothiophene scaffolds as antitumor and anti-influenza virus agents. Part 2
Khurshed Bozorov, Jiang Zhao, Li Fei Nie +7
СтатьяClick Chemistry and ApplicationsRSC Advances2017Цитирований: 10
ABI
Novel deoxyvasicinone derivatives as potent multitarget-directed ligands for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation
Fang Ma, Hongtao Du
Статья2017Цитирований: 6
ABI
Discovery of deoxyvasicinone derivatives as inhibitors of NEDD8-activating enzyme
Hai‐Jing Zhong, Ka‐Ho Leung, Sheng Lin +5
Статья2014Цитирований: 5
ABI
Novel Deoxyvasicinone–Donepezil Hybrids as Potential Multitarget Drug Candidates for Alzheimer’s Disease
Hongtao Du, Xinlian Liu, Jusen Xie +1
Статья2019Цитирований: 5
ABI
Novel tricyclic quinazolinimines and related tetracyclic nitrogen bridgehead compounds as cholinesterase inhibitors with selectivity towards butyrylcholinesterase
Michael Decker, Fabian Krauth, Jochen Lehmann
Статья2005Цитирований: 4
ABI
Synthesis and evaluation of anti-tubercular and antibacterial activities of new 4-(2,6-dichlorobenzyloxy)phenyl thiazole, oxazole and imidazole derivatives. Part 2
Xiaoyun Lu, Xiaobo Liu, Baojie Wan +4
Статья2012Цитирований: 3
ABI
Amine substitution of quinazolinones leads to selective nanomolar AChE inhibitors with ‘inverted’ binding mode
Fouad H. Darras, Sarah Wehle, Guozheng Huang +2
Статья2014Цитирований: 3
ABI
Pharmacodynamic, Pharmacokinetic and Pharmacogenetic Aspects of Drugs Used in the Treatment of Alzheimer’s Disease
Muriel Noetzli, Chin B. Eap
Обзорная статья2013Цитирований: 3
ABI
Pharmacogenetic Considerations in the Treatment of Alzheimer’s Disease
Ramón Cacabelos, Clara Torrellas, Óscar Teijido +1
Обзорная статья2016Цитирований: 3
ABI
Nootropic and Anti-Alzheimer’s Actions of Medicinal Plants: Molecular Insight into Therapeutic Potential to Alleviate Alzheimer’s Neuropathology
Md. Sahab Uddin, Abdullah Al Mamun, Md. Tanvir Kabir +4
Обзорная статья2018Цитирований: 3
ABI
Design, synthesis and evaluation of isaindigotone derivatives as dual inhibitors for acetylcholinesterase and amyloid beta aggregation
Jinwu Yan, Yan‐Ping Li, Wen-Jie Ye +7
Статья2012Цитирований: 2
ABI
New Route to Polynuclear Ni(II) and Cu(II) Complexes with Bridging Oxime Groups That Are Inaccessible by Conventional Preparations
Adedamola A. Opalade, Carlos J. Gómez‐García, Nikolay Gerasimchuk
Статья2019Цитирований: 2
ABI
Novel Solution- and Solid-Phase Syntheses of Heterocyclic Systems
Gaelle Cabon, Bérangère Gaucher, Aline Gégout +2
Статья2003Цитирований: 2
ABI
The amyloid hypothesis for Alzheimer’s disease: a critical reappraisal
John Hardy
Обзорная статья2009Цитирований: 2
ABI
Fluorine in Pharmaceuticals: Looking Beyond Intuition
Klaus Müller, Christoph Faeh, François Diederich
Обзорная статья2007Цитирований: 2
ABI
Acetylcholinesterase inhibitors as Alzheimer therapy: From nerve toxins to neuroprotection
Manjinder Singh, Maninder Kaur, Hitesh Kukreja +3
Обзорная статья2013Цитирований: 2
ABI
Neuroprotective Tri- and Tetracyclic BChE Inhibitors Releasing Reversible Inhibitors upon Carbamate Transfer
Fouad H. Darras, Beata Kling, Jörg Heilmann +1
Статья2012Цитирований: 2
ABI
Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase.
Michal Harel, Isabelle J. Schalk, Laurence Ehret‐Sabatier +6
Статья1993Цитирований: 2
ABI
Synthesis, Biological Evaluation, and Computational Studies of Tri- and Tetracyclic Nitrogen-Bridgehead Compounds as Potent Dual-Acting AChE Inhibitors andhH3Receptor Antagonists
Fouad H. Darras, Steffen Pockes, Guozheng Huang +6
Статья2014Цитирований: 2
ABI
Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.
Inge Grundke‐Iqbal, Khurshid Iqbal, Y C Tung +3
Статья1986Цитирований: 2
ABI
Acetylcholinesterase in Alzheimer's disease
Vincenzo Nicola Talesa
Обзорная статья2001Цитирований: 2
ABI

Работы, на которые ссылается эта работа

Tricyclic Quinazoline Alkaloids: Isolation, Synthesis, Chemical Modification, and Biological Activity

6,7,8,9-Tetrahydropyridoquinazolines, a new class of alkaloids from <i>Mackinlaya</i> species (Araliaceae)

Design, synthesis, and toward a side-ring optimization of tricyclic thieno[2,3-<i>d</i>]pyrimidin-4(3<i>H</i>)-ones and their effect on melanin synthesis in murine B16 cells

<scp>2‐substituted</scp> tricyclic oxazolo[5,4‐<i>d</i>]pyrimidine library: Design, synthesis, and cytotoxicity activity

Synthesis and in vitro biological evaluation of novel diaminothiophene scaffolds as antitumor and anti-influenza virus agents. Part 2

Novel deoxyvasicinone derivatives as potent multitarget-directed ligands for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation

Discovery of deoxyvasicinone derivatives as inhibitors of NEDD8-activating enzyme

Novel Deoxyvasicinone–Donepezil Hybrids as Potential Multitarget Drug Candidates for Alzheimer’s Disease

Novel tricyclic quinazolinimines and related tetracyclic nitrogen bridgehead compounds as cholinesterase inhibitors with selectivity towards butyrylcholinesterase

Synthesis and evaluation of anti-tubercular and antibacterial activities of new 4-(2,6-dichlorobenzyloxy)phenyl thiazole, oxazole and imidazole derivatives. Part 2

Amine substitution of quinazolinones leads to selective nanomolar AChE inhibitors with ‘inverted’ binding mode

Pharmacodynamic, Pharmacokinetic and Pharmacogenetic Aspects of Drugs Used in the Treatment of Alzheimer’s Disease

Pharmacogenetic Considerations in the Treatment of Alzheimer’s Disease

Nootropic and Anti-Alzheimer’s Actions of Medicinal Plants: Molecular Insight into Therapeutic Potential to Alleviate Alzheimer’s Neuropathology

Design, synthesis and evaluation of isaindigotone derivatives as dual inhibitors for acetylcholinesterase and amyloid beta aggregation

New Route to Polynuclear Ni(II) and Cu(II) Complexes with Bridging Oxime Groups That Are Inaccessible by Conventional Preparations

Novel Solution- and Solid-Phase Syntheses of Heterocyclic Systems

The amyloid hypothesis for Alzheimer’s disease: a critical reappraisal

Fluorine in Pharmaceuticals: Looking Beyond Intuition

Acetylcholinesterase inhibitors as Alzheimer therapy: From nerve toxins to neuroprotection

Neuroprotective Tri- and Tetracyclic BChE Inhibitors Releasing Reversible Inhibitors upon Carbamate Transfer

Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase.

Synthesis, Biological Evaluation, and Computational Studies of Tri- and Tetracyclic Nitrogen-Bridgehead Compounds as Potent Dual-Acting AChE Inhibitors and<i>h</i>H<sub>3</sub>Receptor Antagonists

Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.

Acetylcholinesterase in Alzheimer's disease